XRN Chiron Real Estate Inc.

8-K Current Report
Filed: February 25, 2026
Financials
Real Estate Investment Trusts

Chiron Real Estate Inc. (XRN) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
4 items

  • Item 2.02: Results of Operations and Financial Condition
  • Item 5.03: Amendments to Articles of Incorporation or Bylaws
  • Item 7.01: Regulation FD Disclosure
  • Item 8.01: Other Events

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • Q4 or full-year earnings press release referenced via exhibit — actual financial figures found only in the attached exhibit (likely Ex. 99.1)
  • Filing structured to limit legal liability — disclosure explicitly excluded from Section 18 Exchange Act coverage
+1 more insights

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • Name change only: Global Medical REIT Inc. → Chiron Real Estate Inc., effective Feb 23, 2026
  • Operating Partnership renamed from Global Medical REIT L.P. → Chiron Real Estate LP simultaneously
+2 more insights

Item 7.01 · Regulation FD Disclosure

  • Reg FD boilerplate only — no material business, operational, or financial information disclosed in this filing section

Item 8.01 · Other Events

  • Ticker symbols changed Feb 23, 2026: common stock GMRE → XRN; preferred series A GMRE PrA → XRN PrA; preferred series B GMRE PrB → XRN PrB
  • Preferred stock terms unchanged: Series A carries 7.50% cumulative redeemable rate, Series B carries 8.00% cumulative redeemable rate
+1 more insights

Other Chiron Real Estate Inc. 8-K Filings

Get deeper insights on Chiron Real Estate Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.